Revisiting the solubility concept of pharmaceutical compounds

被引:9
作者
Blasko, A [1 ]
Leahy-Dios, A [1 ]
Nelson, WO [1 ]
Austin, SA [1 ]
Killion, RB [1 ]
Visor, GC [1 ]
Massey, IJ [1 ]
机构
[1] Roche Biosci, Palo Alto, CA 94304 USA
来源
MONATSHEFTE FUR CHEMIE | 2001年 / 132卷 / 07期
关键词
solubility; aqueous solutions; pH-STAT; UV/Vis turbidimetry; shake flask;
D O I
10.1007/s007060170065
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The kinetic and thermodynamic solubilities of Roche (Ro) pharmaceutical compounds were determined by HPLC, titrimetry, and UV/Vis spectroscopy in aqueous buffers and in nonbuffered systems. For kinetic solubility, a turbidimetric method that allows the rapid determination of solubilities using small amounts of compounds (5-50 mg) was used. Two types of precipitation were observed during the kinetic solubility determinations: i) a disperse precipitation where the solution became foggy with very small particles uniformly distributed in the solution, and ii) discrete precipitation characterized by fort-nation of crystals that rapidly sediment. The thermodynamic solubility was determined by shake flask and titrimetrically using a pH-STAT. The pH-STAT titrimetric method for the pH-thermodynamic solubility profile determination eliminates the buffer species and represents a new way to approach the solubility characterization of pharmaceutical compounds. The strengths of the turbidimetric method for determining the kinetic solubility are its rapidity, minimal compound requirements, and suitability for high throughput screening. The limitations are that the maximum solubility is limited to less than 100 mg . cm(-3), and the precipitation of trace impurities cannot be distinguished from precipitation of the analyte. The pH-STAT titrimetric approach for the thermodynamic solubility has a lower throughput and is suitable for the characterization of the lead candidate. It is not limited in its solubility range and provides a common basis for the comparison of the solubility values at different pH values in contrast to traditional buffered systems.
引用
收藏
页码:789 / 798
页数:10
相关论文
共 15 条
[1]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]   PREDICTIVE RELATIONSHIPS IN THE WATER SOLUBILITY OF SALTS OF A NONSTEROIDAL ANTI-INFLAMMATORY DRUG [J].
ANDERSON, BD ;
CONRADI, RA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (08) :815-820
[3]   pH-metric solubility. 2: Correlation between the acid-base titration and the saturation shake-flask solubility-pH methods [J].
Avdeef, A ;
Berger, CM ;
Brownell, C .
PHARMACEUTICAL RESEARCH, 2000, 17 (01) :85-89
[4]  
ELGIBALY I, 1999, B PHARM SCI ASSIUT U, V22, P55
[5]  
Hoerter D., 1997, Advanced Drug Delivery Reviews, V25, P3
[6]   Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings [J].
Lipinski, CA ;
Lombardo, F ;
Dominy, BW ;
Feeney, PJ .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) :3-25
[7]  
LIPINSKI CA, 1999, 217 ACS NAT M AN CA
[8]  
RAVIN LJ, 1990, REMINGTONS PHARMACEU, P212
[9]   PH-DEPENDENT SOLUBILITY AND DISSOLUTION OF BUPIVACAINE AND ITS RELEVANCE TO THE FORMULATION OF A CONTROLLED RELEASE SYSTEM [J].
SHAH, JC ;
MANIAR, M .
JOURNAL OF CONTROLLED RELEASE, 1993, 23 (03) :261-270
[10]  
SWARBRICK J, 1995, ENCY PHARMACEUTICAL, V13, P453